Microbiome Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Global Microbiome Therapeutics Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Microbiome Therapeutics Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
   3. Global Microbiome Therapeutics Market Outlook: Therapy
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Therapy, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
         1. Probiotics
         2. Prebiotics
         3. Postbiotics
         4. Live Biotherapeutic Products (LBP)
         5. Fecal Microbiota Therapy (FMT)
         6. Others
      4. Market Attractiveness Analysis: Therapy
   4. Global Microbiome Therapeutics Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
         1. Gastrointestinal Disorders
         2. Autoimmune Disorders
         3. Metabolic Disorders
         4. Oncology
         5. Neurological Disorders
         6. Others
      4. Market Attractiveness Analysis: Application
   5. Global Microbiome Therapeutics Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
         1. Oral
         2. Rectal
         3. Topical
         4. Others
      4. Market Attractiveness Analysis: Route of Administration
5. Global Microbiome Therapeutics Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Microbiome Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Therapy
      3. By Application
      4. By Route of Administration
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
      1. Probiotics
      2. Prebiotics
      3. Postbiotics
      4. Live Biotherapeutic Products (LBP)
      5. Fecal Microbiota Therapy (FMT)
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
      1. Gastrointestinal Disorders
      2. Autoimmune Disorders
      3. Metabolic Disorders
      4. Oncology
      5. Neurological Disorders
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
      1. Oral
      2. Rectal
      3. Topical
      4. Others
   7. Market Attractiveness Analysis
7. Europe Microbiome Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Therapy
      3. By Application
      4. By Route of Administration
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
      1. Probiotics
      2. Prebiotics
      3. Postbiotics
      4. Live Biotherapeutic Products (LBP)
      5. Fecal Microbiota Therapy (FMT)
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
      1. Gastrointestinal Disorders
      2. Autoimmune Disorders
      3. Metabolic Disorders
      4. Oncology
      5. Neurological Disorders
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
      1. Oral
      2. Rectal
      3. Topical
      4. Others
   7. Market Attractiveness Analysis
8. East Asia Microbiome Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Therapy
      3. By Application
      4. By Route of Administration
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
      1. Probiotics
      2. Prebiotics
      3. Postbiotics
      4. Live Biotherapeutic Products (LBP)
      5. Fecal Microbiota Therapy (FMT)
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
      1. Gastrointestinal Disorders
      2. Autoimmune Disorders
      3. Metabolic Disorders
      4. Oncology
      5. Neurological Disorders
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
      1. Oral
      2. Rectal
      3. Topical
      4. Others
   7. Market Attractiveness Analysis
9. South Asia & Oceania Microbiome Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Therapy
      3. By Application
      4. By Route of Administration
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
      1. Probiotics
      2. Prebiotics
      3. Postbiotics
      4. Live Biotherapeutic Products (LBP)
      5. Fecal Microbiota Therapy (FMT)
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
      1. Gastrointestinal Disorders
      2. Autoimmune Disorders
      3. Metabolic Disorders
      4. Oncology
      5. Neurological Disorders
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
      1. Oral
      2. Rectal
      3. Topical
      4. Others
   7. Market Attractiveness Analysis
10. Latin America Microbiome Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
       1. By Country
       2. By Therapy
       3. By Application
       4. By Route of Administration
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
       1. Probiotics
       2. Prebiotics
       3. Postbiotics
       4. Live Biotherapeutic Products (LBP)
       5. Fecal Microbiota Therapy (FMT)
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
       1. Gastrointestinal Disorders
       2. Autoimmune Disorders
       3. Metabolic Disorders
       4. Oncology
       5. Neurological Disorders
       6. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
       1. Oral
       2. Rectal
       3. Topical
       4. Others
    7. Market Attractiveness Analysis
11. Middle East & Africa Microbiome Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
       1. By Country
       2. By Therapy
       3. By Application
       4. By Route of Administration
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Therapy, 2026-2033
       1. Probiotics
       2. Prebiotics
       3. Postbiotics
       4. Live Biotherapeutic Products (LBP)
       5. Fecal Microbiota Therapy (FMT)
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2026-2033
       1. Gastrointestinal Disorders
       2. Autoimmune Disorders
       3. Metabolic Disorders
       4. Oncology
       5. Neurological Disorders
       6. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026-2033
       1. Oral
       2. Rectal
       3. Topical
       4. Others
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Microbiome Therapeutics Innovation Group
          1. Overview
          2. Segments and Product
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. SERES Therapeutics
       3. Vedanta Biosciences, Inc.
       4. Enterome
       5. Ferring
       6. Evotec AG
       7. Synlogic
       8. Osel Inc.
       9. OxThera
       10. AOBiome
       11. Immuron Limted
       12. MRM Health NV
       13. Microbiotica
       14. BiomeBank
       15. Finch Therapeutics Group, Inc.
       16. NuBiyota
       17. MaaT Pharma
       18. LNC Therapeutics
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations